Maxgrip Pharmaceuticals Private Limited
About Maxgrip Pharmaceuticals Private Limited
Data last updated:
Maxgrip Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 12 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2013PTC058895. Its GSTIN is 09AAICM8972G1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jitendra Kumar Gupta and Maya Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 174 Flat No. 107 Gyan Khand – 1 Indira Puram, Ghaziabad, Uttar Pradesh, India – 201002.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.84 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹18,247 (net margin 1.5%) and EBITDA of ₹34,544 (EBITDA margin 2.9%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Maxgrip Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 174 Flat No. 107 Gyan Khand – 1 Indira Puram, Ghaziabad, Uttar Pradesh, India – 201002
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Maxgrip Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxgrip Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Maxgrip Pharmaceuticals Private Limited, buy the company report.
Financials of Maxgrip Pharmaceuticals Private Limited
FY 2025 filings availableMaxgrip Pharmaceuticals Private Limited reported revenue of ₹11.84 Lakh (up 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34,544 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18,247 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxgrip Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maxgrip Pharmaceuticals Private Limited
Maxgrip Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Kumar Gupta | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
| Maya Gupta | Director | 12 Aug 2013 | 13 Years 2 Months | Current |
Peer comparison
Maxgrip Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Geniosporum Pharmaceuticals Private Limited | ₹11.87 Lakh (FY 2020) | 73.0% | New Delhi, Delhi, India | |||
| Healtharms Pharmaceuticals Private Limited | ₹11.85 Lakh (FY 2024) | 25.0% | Nawada, Bihar, India | |||
| Maxgrip Pharmaceuticals Private Limitedthis company | ₹11.84 Lakh (FY 2024) | ₹18,247 | 1.5% | 14.0% | Ghaziabad, Uttar Pradesh, India | |
| Dermawell Pharmaceuticals Private Limited | ₹11.78 Lakh (FY 2024) | 152.0% | New Delhi, Delhi, India |
To see the full peer comparison of Maxgrip Pharmaceuticals Private Limited, buy the company report.
Auditor
Maxgrip Pharmaceuticals Private Limited is audited by GAURAV H AGARWAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV H AGARWAL | FY 2017 | 407436 |
Shareholding
The shareholding of Maxgrip Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Maxgrip Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maxgrip Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxgrip Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxgrip Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICM8972G1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxgrip Pharmaceuticals Private Limited, buy the company report.
Recent activity
Maxgrip Pharmaceuticals Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Jitendra Kumar Gupta was appointed as Director on 12 Aug 2013.
Frequently asked questions
Maxgrip Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in retailers, within the trading industry. It was incorporated on 12 August 2013 (13+ years old) and is registered under CIN U85191UP2013PTC058895.
Maxgrip Pharmaceuticals has 2 current directors:
- Jitendra Kumar Gupta - Director
- Maya Gupta - Director
The latest financial statements of Maxgrip Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxgrip Pharmaceuticals is 09AAICM8972G1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Maxgrip Pharmaceuticals is U85191UP2013PTC058895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxgrip Pharmaceuticals was incorporated on 12 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Maxgrip Pharmaceuticals by revenue are Geniosporum Pharmaceuticals Private Limited, Healtharms Pharmaceuticals Private Limited, Dermawell Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (other hospital and medical care activities).
Jitendra Kumar Gupta was appointed as Director on 12 Aug 2013. Maya Gupta was appointed as Director on 12 Aug 2013.
The registered office of Maxgrip Pharmaceuticals is at Plot No. 174 Flat No. 107 Gyan Khand – 1 Indira Puram, Ghaziabad, Uttar Pradesh, India – 201002.
Maxgrip Pharmaceuticals operates in the trading industry, in the retailers segment.
The compliance status of Maxgrip Pharmaceuticals is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
